Journal Article

The mutational spectrum of human malignant autosomal recessive osteopetrosis

Cristina Sobacchi, Annalisa Frattini, Paul Orchard, Oscar Porras, Ilhan Tezcan, Marino Andolina, Riyana Babul-Hirji, Ivo Baric, Natalie Canham, David Chitayat, Sophie Dupuis-Girod, Ian Ellis, Amos Etzioni, Anders Fasth, Alain Fisher, Bert Gerritsen, Virginia Gulino, Edwin Horwitz, Verena Klamroth, Edoardo Lanino, Massimiliano Mirolo, Antonio Musio, Gert Matthijs, Shigeaki Nonomaya, Luigi D. Notarangelo, Hans D. Ochs, Andrea Superti Furga, Jouni Valiaho, Johan L.K. van Hove, Mauno Vihinen, Dragana Vujic, Paolo Vezzoni and Anna Villa

in Human Molecular Genetics

Volume 10, issue 17, pages 1767-1773
Published in print August 2001 | ISSN: 0964-6906
Published online August 2001 | e-ISSN: 1460-2083 | DOI:
The mutational spectrum of human malignant autosomal recessive osteopetrosis

Show Summary Details


Human malignant infantile osteopetrosis (arOP; MIM 259700) is a genetically heterogenous autosomal recessive disorder of bone metabolism, which, if untreated, has a fatal outcome. Our group, as well as others, have recently identified mutations in the ATP6i (TCIRG1) gene, encoding the a3 subunit of the vacuolar proton pump, which mediates the acidification of the bone/osteoclast interface, are responsible for a subset of this condition. By sequencing the ATP6i gene in arOP patients from 44 unrelated families with a worldwide distribution we have now established that ATP6i mutations are responsible for ∼50% of patients affected by this disease. The vast majority of these mutations (40 out of 42 alleles, including seven deletions, two insertions, 10 nonsense substitutions and 21 mutations in splice sites) are predicted to cause severe abnormalities in the protein product and are likely to represent null alleles. In addition, we have also analysed nine unrelated arOP patients from Costa Rica, where this disease is apparently much more frequent than elsewhere. All nine Costa Rican patients bore either or both of two missense mutations (G405R and R444L) in amino acid residues which are evolutionarily conserved from yeast to humans. The identification of ATP6i gene mutations in two families allowed us for the first time to perform prenatal diagnosis: both fetuses were predicted not to be affected and two healthy babies were born. This study contributes to the determination of genetic heterogeneity of arOP and allows further delineation of the other genetic defects causing this severe condition.

Journal Article.  4960 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.